UNIM, a developer of software for oncological diagnostics, has signed a contract with the British AstraZeneca to create a platform for conducting educational councils of physicians. The Moscow company is adapting its main development for a foreign partner - the Digital Pathology software.

This year, AstraZeneca plans to organize an educational project on the platform, the project will be aimed at raising the standards of lung cancer diagnostics. The project is scheduled to start in June and will last for five months. According to the founder and co-owner of UNIM Alexey Remez, the cost of the contract with AstraZeneca amounts to several tens of thousands of dollars.

Original (in Russian)